ARTICLE | Company News
Ascletis, Roche deal
April 22, 2013 7:00 AM UTC
Roche granted Ascletis exclusive, Chinese rights to the pharma's HCV compound danoprevir. Under the deal, Ascletis will fund development, regulatory affairs and manufacturing in China. The partners wi...